What is CBD Cannabidiol?
Medical Marijuana Information
Cannabidiol is one of the several compounds or cannabinoids found in marijuana. Also referred to as CBD, cannabidiol is a non “high” producing cannabinoid that has many medical uses that have been found so far.
Cannabidiol is known to be a great medicine to help with convulsions, inflammation, anxiety, nausea, inhibiting cancer cell growth, reducing breast cancer cell invasiveness, and also may help patients dealing with schizophrenia. Cannabidiol also has antioxidant properties.
Best of all about cannabidiol is it may be able to take over as a non-toxic alternative treatment for many patients that are currently taking very nasty chemical drugs for their ailments.
Cannabidiol has been shown to relieve convulsion, inflammation, anxiety, and nausea, as well as inhibit cancer cell growth. Recent studies have shown cannabidiol to be as effective as atypical antipsychotics in treating schizophrenia. Studies have also shown that it may relieve symptoms of dystonia.
In November 2007, it was reported that CBD reduces growth of aggressive human breast cancer cells in vitro and reduces their invasiveness.
A 2008 study published in the British Journal of Psychiatry showed significant differences in Oxford-Liverpool Inventory of Feelings and Experiences scores between three groups: The first consisted of non-cannabis users, the second consisted of users with Δ9-THC detected, and the third consisted of users with both Δ9-THC and CBD detected. The Δ9-THC only group score showed higher levels of positive schizophrenia-like symptoms and higher levels of delusions than the Δ9-THC and CBD group, whereas the Δ9-THC and CBD group had significantly lower introvertive anhedonia scores than the Δ9-THC only group and non-cannabis user group. This research indicates that CBD acts as an anti-psychotic and may counteract the potential effects of THC on individuals with latent schizophrenia.[9
Medically, it appears to relieve convulsion, inflammation, anxiety, and nausea, and to inhibit cancer cell growth. Recent studies have shown cannabidiol to be as effective as atypical antipsychotics in treating schizophrenia. In November 2007 it was reported that CBD reduces growth of aggressive human breast cancer cells in vitro and reduces their invasiveness. It thus represents the first non-toxic exogenous agent that can lead to down-regulation of tumor aggressiveness. It is also a neuroprotectiveantioxidant.